Literature DB >> 11950021

Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal antiinflammatory drugs.

Christelle Sanchez1, Marguarida M Mateus, Marie-Paule Defresne, Jean-Michel R Crielaard, Jean-Yves L Reginster, Yves E Henrotin.   

Abstract

OBJECTIVES: To investigate the longterm effects (12 days) of nonsteroidal antiinflammatory drugs [NSAID: aceclofenac (ACECLO), sodium diclofenac (DICLO), indomethacin (INDO), nimesulide (NIM), rofecoxib (ROFE), celecoxib (CELE), piroxicam (PIROX), and ibuprofen (IBUP)] on the metabolism of human chondrocytes cultured in alginate beads.
METHODS: Enzymatically isolated osteoarthritic (OA) chondrocytes were cultured in alginate beads in a well defined culture medium for 12 days. The DNA content was measured according to a fluorimetric method and cell proliferation was determined by the incorporation of 3H-thymidine in the newly synthesized DNA. Interleukin 6 (IL-6) and IL-8, stromelysin [matrix metalloproteinase-3 (MMP-3)], and aggrecan (AGG) production were assayed by specific enzyme amplified sensitivity immunoassays, and prostaglandin E2 (PGE2) production by specific radioimmunoassay. All NSAID were tested at the mean peak plasma concentration (Cmax) obtained after oral administration of a therapeutic dose.
RESULTS: In alginate beads, chondrocytes synthesized high amounts of AGG, which were largely (98%) immobilized in the alginate matrix. A large amount (43%) of the IL-8 produced was stored in the alginate beads, whereas almost all IL-6 production (94%) was released in the culture supernatant. At the therapeutic concentration, all NSAID tested fully blocked PGE2 production. ACECLO, DICLO, INDO, NIM significantly inhibited basal and IL-1beta stimulated IL-6 production; CELE and IBUP only inhibited IL-1beta stimulated IL-6 production; and ROFE and PIROX had no significant effects. No NSAID showed significant effects on basal and IL-1beta stimulated IL-8 production, except CELE and IBUP, which slightly increased basal IL-8 production. ACECLO and INDO increased AGG content by 25% in the alginate beads, while the other NSAID were without significant effect. No NSAID were able to modify the inhibitory effect of IL-1beta on AGG production. NSAID did not modify MMP-3 production.
CONCLUSION: The mechanism of action of NSAID seems to be multifactorial and not limited to the inhibition of cyclooxygenases. Further, in our culture conditions, at the Cmax and by comparison with other NSAID, ACECLO and INDO show an advantageous activity profile. They fully blocked PGE2 production, inhibited IL-6 synthesis, and increased aggrecan synthesis. These effects appear advantageous for the longterm treatment of chronic joint diseases such as osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950021

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  14 in total

1.  [Adipocytokines in rheumatoid arthritis and obesity].

Authors:  Nicola Fagerer; Werner Kullich
Journal:  Wien Med Wochenschr       Date:  2010-08

2.  Bradykinin and B₂ receptor antagonism in rat and human articular chondrocytes.

Authors:  S Meini; P Cucchi; C Catalani; F Bellucci; S Giuliani; C A Maggi
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 3.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

4.  Novel effects mediated by bradykinin and pharmacological characterization of bradykinin B2 receptor antagonism in human synovial fibroblasts.

Authors:  F Bellucci; P Cucchi; C Catalani; S Giuliani; S Meini; C A Maggi
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

5.  Curcumin inhibits pro-inflammatory mediators and metalloproteinase-3 production by chondrocytes.

Authors:  M Mathy-Hartert; I Jacquemond-Collet; F Priem; C Sanchez; C Lambert; Y Henrotin
Journal:  Inflamm Res       Date:  2009-07-05       Impact factor: 4.575

Review 6.  Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis.

Authors:  Manon C Zweers; Tineke N de Boer; Joël van Roon; Johannes W J Bijlsma; Floris P J G Lafeber; Simon C Mastbergen
Journal:  Arthritis Res Ther       Date:  2011-09-21       Impact factor: 5.156

7.  Chitosan enriched three-dimensional matrix reduces inflammatory and catabolic mediators production by human chondrocytes.

Authors:  Frederic Oprenyeszk; Christelle Sanchez; Jean-Emile Dubuc; Véronique Maquet; Catherine Henrist; Philippe Compère; Yves Henrotin
Journal:  PLoS One       Date:  2015-05-28       Impact factor: 3.240

8.  Inducible hydrogen sulfide synthesis in chondrocytes and mesenchymal progenitor cells: is H2S a novel cytoprotective mediator in the inflamed joint?

Authors:  Bridget Fox; Jan-Thorsten Schantz; Richard Haigh; Mark E Wood; Phillip K Moore; Nick Viner; Jeremy P E Spencer; Paul G Winyard; Matthew Whiteman
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

9.  Upregulation of IL-6, IL-8 and CCL2 gene expression after acute inflammation: Correlation to clinical pain.

Authors:  Xiao-Min Wang; May Hamza; Tian-Xia Wu; Raymond A Dionne
Journal:  Pain       Date:  2009-02-23       Impact factor: 7.926

10.  Cartilage stem/progenitor cells are activated in osteoarthritis via interleukin-1β/nerve growth factor signaling.

Authors:  Yangzi Jiang; Changchang Hu; Shuting Yu; Junwei Yan; Hsuan Peng; Hong Wei Ouyang; Rocky S Tuan
Journal:  Arthritis Res Ther       Date:  2015-11-17       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.